The prevalence, aetiologies, and clinical consequences of tricuspid regurgitation associated with severe degenerative mitral regurgitation

与严重退行性二尖瓣反流相关的三尖瓣反流的患病率、病因和临床后果

阅读:1

Abstract

AIMS: The prevalence, the aetiologies, and the clinical features of tricuspid regurgitation (TR) in the context of concomitant degenerative mitral valve (MV) disease are poorly defined. This paper aims to assess the prevalence, determinants, and clinical consequences of TR in severe degenerative mitral regurgitation (DMR). METHODS AND RESULTS: Clinical and echocardiographic characteristics were collected among patients with severe DMR. A total of 884 patients were included in our study, 31% with ≥ moderate TR. Tricuspid valve prolapse (TVP) was the most common aetiology (487 patients, 55%), followed by atrial functional TR (AFTR, 172 patients, 19%) and ventricular functional TR (VFTR, 42 patients, 5%), while TR aetiology was classified as mixed in 183 (21%) patients. Patients with TVP were younger and had a better clinical presentation, few comorbidities, and less haemodynamically relevant TR. Patients with VFTR were characterized by older age, worse clinical presentation, and both highest comorbidity rate and prevalence of >mild TR. Patients with AFTR showed an intermediate profile of clinical presentation and comorbidities and the largest tricuspid annulus (TA) diameter. MV surgery was performed in 785 (88%) patients; 132 (15%) underwent simultaneous TV intervention, more often patients with AFTR (32%). TA dilatation [odds ratio (OR) 3.68, 95% confidence interval (CI) 2.05-6.62, P < 0.001] and >mild TR (OR 9.30, 95% CI 5.10-16.95, P < 0.001) were independently associated with TV intervention. CONCLUSION: In patients with severe DMR, TR presents with different aetiologies, clinical features, and echocardiographic phenotypes that require a comprehensive assessment at the time of DMR surgery to ensure the best management for these patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。